EU SEP regulation reveal; PTAB reform reactions; IPBC Global speakers; Ravgen assertion campaign; carmaker litigation data; plus much more

Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week.

MONDAY 24 April

Active case management and the role of boutique patent firms in pan-European disputes. Read more here

Data dive: US patent litigation against top automakers rose 32% in 2022. Read more here

TUESDAY 25 April

Amgen’s Federal Circuit victory vindicates $13.4 billion Otezla IP acquisition. Read more here

300 million reasons why patent owners love litigating in Texas. Read more here

New draft European Commission SEP regulation shows tweaks but no rewrite. Read more here


Ravgen continues winning streak in big-money patent assertion campaign. Read more here

PTAB experts react to discretionary denial reform package. Read more here


Weekly column: Chinese IP theft is a problem, but is not to blame for US tech woes. Read more here

Commissioner Breton takes aim at “bad faith” patent licensors as final SEP policy proposal released. Read more here

Xiaomi, Meta and Sisvel to speak at IPBC Global 2023. Read more here

FRIDAY 28 April

European Commission proposes unitary SPC as part of mixed bag of pharma IP reforms. Read more here

US PTAB reform proposal comes under fire at House hearing. Read more here


Opinion: Some gold nuggets for patentees in the PTAB reform proposal. Read more here

Unlock unlimited access to all IAM content